Yang Huimei, Chen Yan, Fu Mingxia
Department of Emergency, Hubei University of Medicine, Shiyan, China.
Department of Blood Purification, Hubei University of Medicine, Shiyan, China.
Evid Based Complement Alternat Med. 2022 Jul 8;2022:2363877. doi: 10.1155/2022/2363877. eCollection 2022.
To evaluate the efficacy of risk management in the nursing of critically ill patients on continuous renal replacement therapy (CRRT).
In this retrospective study, 80 critically ill patients on continuous renal replacement therapy in our hospital from February 2020 to February 2021 were recruited. They were randomly assigned to receive either the risk management treatment (risk management group) or the conventional management treatment (conventional management group) via the random number table method. Outcome measurements included the occurrence of adverse events, complications, psychological status, quality of life, treatment compliance, duration of CRRT, and nursing satisfaction.
Risk management treatment was associated with lower incidence of adverse events compared to conventional management treatment ( value < 0.05). The risk management group also resulted in a lower incidence of complications compared to the conventional management group ( value < 0.05). Patients who received risk management treatments demonstrated a significantly lower anxiety/depression level and a higher World Health Organization Quality of Life Brief Version (WHOQOL-BREF) ( value < 0.05). The risk management group resulted in more cases with high compliance and fewer cases with moderate and poor compliance ( < 0.05). Risk management was associated with more cases with a CRRT duration less than 36 hours and 36-48 hours and fewer cases with a duration longer than 48 h ( = 2.999, value < 0.05). Patients who were given a risk management treatment had a higher nursing satisfaction compared to conventional management treatment ( = 4.501, value < 0.05).
Risk management treatment in caring of critically ill patients on CRRT shows better efficacy than conventional management treatments.
评估风险管理在接受持续肾脏替代治疗(CRRT)的重症患者护理中的效果。
在这项回顾性研究中,纳入了2020年2月至2021年2月在我院接受持续肾脏替代治疗的80例重症患者。通过随机数字表法将他们随机分为接受风险管理治疗组(风险管理组)和传统管理治疗组(传统管理组)。观察指标包括不良事件的发生情况、并发症、心理状态、生活质量、治疗依从性、CRRT持续时间以及护理满意度。
与传统管理治疗相比,风险管理治疗的不良事件发生率较低( 值<0.05)。与传统管理组相比,风险管理组的并发症发生率也较低( 值<0.05)。接受风险管理治疗的患者焦虑/抑郁水平显著较低,世界卫生组织生活质量简表(WHOQOL-BREF)得分较高( 值<0.05)。风险管理组高依从性的病例更多,中度和低依从性的病例更少(<0.05)。风险管理与CRRT持续时间小于36小时和36 - 48小时的病例更多以及持续时间超过48小时的病例更少相关( =2.999, 值<0.05)。接受风险管理治疗的患者比接受传统管理治疗的患者护理满意度更高( =4.501, 值<0.05)。
在护理接受CRRT的重症患者时,风险管理治疗比传统管理治疗显示出更好的效果。